'Chronic hcv' diaporamas de présentation

Advances in Hepatitis C Identification and Treatment

Advances in Hepatitis C Identification and Treatment. Camilla S. Graham, MD, MPH Division of Infectious Diseases Beth Israel Deaconess Medical Center. Hepatitis C and Occupational Health. Hepatitis C affects 4 -5 million people in the US. Impact on employees:

865 views • 86 slides

Advances in Hepatitis C Identification and Treatment

Advances in Hepatitis C Identification and Treatment. Developed by Camilla S. Graham, MD, BIDMC, 5/5/15. cgraham@bidmc.harvard.edu . Slides can be selected or altered as needed. Disclosures. 75% of People with Hepatitis C in the US are Baby Boomers. Identifying Patients with Hepatitis C.

593 views • 59 slides

HIV and Hepatitis C Co-infection

HIV and Hepatitis C Co-infection. Amy Kindrick, M.D., M.P.H. San Francisco AIDS ETC National HIV/AIDS Clinical Consultation Center. February 12, 2002. The Hepatitis C Virus. Is There Only One Kind of Hepatitis?. HCV Infection: Epidemiology. Major healthcare problem worldwide

667 views • 49 slides

Hepatitis C Virus From Discovery to Cure

Hepatitis C Virus From Discovery to Cure. David R Nelson MD Assistant Vice President for Research Professor of Medicine Director, Clinical and Translational Science Institute University of Florida Gainesville, USA. Disclosures. David R Nelson, MD,

810 views • 40 slides

Hepatitis C Virus Infection: Natural History + Therapy

Hepatitis C Virus Infection: Natural History + Therapy. Brian L. Pearlman MD FACP Medical Director, Center for Hepatitis C Atlanta Medical Center, Atlanta, Georgia Adjunct Professor of Medicine, Medical College of Georgia Adjunct Professor of Medicine, Emory School of Medicine December, 2015.

383 views • 37 slides

Ribavirin ( Copegus , Rebetol , Ribasphere )

Ribavirin ( Copegus , Rebetol , Ribasphere ). Prepared by: David Spach, MD and H. Nina Kim, MD Last Updated: February 14, 2014. Ribavirin ( Copegus , Rebetol , Ribasphere ). Background. Ribavirin: Mechanism of Action. Defective HCV Particle. Th2. Th1. CTL. RBV. IFN- ?.

684 views • 33 slides

Hepatitis C

Hepatitis C. Cengiz Pata Gastroenterology Department, Yeditepe University. Hepatitis C Virus Infection Magnitude of the Problem. Nearly 4 million persons in United States infected Approximately 35,000 new cases yearly 85% of new cases become chronic Leading cause of Chronic liver disease

463 views • 30 slides

INJECTION DRUG USE IN METROPOLITAN CINCINNATI

Judith Feinberg, MD Professor of Medicine University of Cincinnati College of Medicine November 12, 2012. INJECTION DRUG USE IN METROPOLITAN CINCINNATI. Disclosures. Advisory Board: Janssen, GlaxoSmithKline/ViiV & Merck Shareholder: Pfizer (stock)

417 views • 29 slides

SC DHEC Hepatitis C Surveillance, Testing & Counseling Pilot Projects, Hepatitis C Coalition

254 views • 25 slides

Hepatitis C Needs Assessment:

Hepatitis C Needs Assessment:. Contributions from the National HCV Diagnosis and Local Clinical Databases. Key questions. How many people have been diagnosed with HCV in Scotland? How many people have attended a clinic for HCV treatment/care?

379 views • 24 slides

Viral Hepatitis B and C Epidemiology in North Carolina 2018

August 2019 Division of Public Health/Epidemiology Section/Communicable Disease Branch HIV/STD/Hepatitis Surveillance Unit. Viral Hepatitis B and C Epidemiology in North Carolina 2018. Where to find Hepatitis B/C Information?. http://epi.publichealth.nc.gov/cd/stds/figures.html.

264 views • 16 slides

Boceprevir with PEG + RBV in Genotype 1 SPRINT -1

164 views • 7 slides

Hepcinat

Hepcinat ( Sofosbuvir ) is not used on its own, Rather, it is presented along with other medications

99 views • 7 slides

Peginterferon alfa - 2b + Ribavirin in Blacks & Non-Hispanic Whites

157 views • 6 slides

M.C. Thurnheer 1,2 , S. Wildbolz 1 , U.Breckner 3 , H. Furrer 1

Improving medical care for people who inject drugs in Switzerland: results from an integrated approach to HIV and HCV management. M.C. Thurnheer 1,2 , S. Wildbolz 1 , U.Breckner 3 , H. Furrer 1. Koda Bern: On-site heroin maintenance treatment for PWID

133 views • 4 slides